Loading…

P1189: INITIAL SAFETY RUN‐IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Saved in:

Bibliographic Details
Published in:	HemaSphere 2022-06, Vol.6 (Suppl), p.1075-1076
Main Authors:	McMillan, A., Haioun, C., Sancho, J.‐M., Viardot, A., Rodriguez Izquierdo, A., Donato Martin, E. M., García‐Sancho, A. M., Sandoval‐Sus, J., Tilly, H., Vandenberghe, E., Hirata, J., Choudhry, P., Chang, Y. M., Musick, L., Matasar, M.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!